ADIAL PHARMACEUTICALS INC (ADIL)

US00688A2050 - Common Stock

1.55  +0.14 (+9.93%)

After market: 1.55 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
2.83M4.00M6.06M4.40M6.78M
Receivables
N/AN/AN/AN/AN/A
Other Current Assets
371.60K780.00K400.00K730.00K900.00K
Total Current Assets
3.20M4.78M6.46M5.14M7.67M
 
Non-Current Assets
PPE Net
N/A240.00K300.00KN/AN/A
Investments And Advances
1.53MN/AN/AN/AN/A
Goodwill
N/A250.00K250.00KN/AN/A
Intangibles
3.91K460.00K460.00K10.00K10.00K
Other Non-Current Assets
N/AN/AN/AN/AN/A
Total Non-Current Assets
1.54M950.00K1.01M350.00K10.00K
 
TOTAL ASSETS
4.74M5.73M7.47M5.49M7.68M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
525.69K1.39M2.43M860.00K350.00K
Accounts Payable
127.39K390.00K290.00K650.00K190.00K
Other Current Liabilities
N/A10.00K10.00KN/AN/A
Total Current Liabilities
653.08K1.79M2.72M1.51M540.00K
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Deferred Taxes/Income
N/A20.00K20.00KN/AN/A
Other Non-Current Liabilities
N/A640.00K1.22MN/AN/A
Total Non-Current Liabilities
0.00670.00K1.25M0.000.00
 
TOTAL LIABILITIES
653.08K2.46M3.97M1.51M540.00K
 
SHAREHOLDERS' EQUITY
Retained Earnings
-68.80M-63.67M-50.94M-31.52M-20.63M
Additional Paid In Capital
72.88M66.92M54.43M35.49M27.76M
Common Shares
1.66K30.00K20.00K10.00K10.00K
Shares Outstanding
1.66M1.07M840.00K580.00K410.00K
Tangible Book Value per Share
2.452.403.336.8617.39
Total Shareholders' Equity
4.08M3.28M3.51M3.99M7.14M
 
TOTAL LIABILITIES AND EQUITY
4.74M5.73M7.47M5.49M7.68M
 
Statistics
Current Ratio
4.902.672.383.4014.20
Return On Assets (ROA)
-108.16%-222.16%-259.97%-198.36%-111.85%
Return On Equity (ROE)
-125.46%-388.11%-553.28%-272.93%-120.31%

All data in USD

Charts